Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-21

FDA Approved: EBANGA — Original Application (Emergent Manufacturing Operations Baltimore, LLC)

View source ↗

Summary

FDA approves EBANGA (ansuvimab) from Emergent Manufacturing Operations Baltimore, LLC through an original biologics license application for passive immunity in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebanga (ansuvimab-zykl)

Snippet

ORIG AP for EBANGA (ANSUVIMAB)